Eudaimonia Partners’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-3,431
Closed -$1.49M – 408
2022
Q1
$1.49M Buy
+3,431
New +$1.44M 0.25% 107
2021
Q3
$1.14M Buy
2,923
+238
+9% +$101K 0.21% 132
2021
Q2
$1.19M Buy
2,685
+616
+30% +$269K 0.22% 119
2021
Q1
$867K Buy
2,069
+63
+3% +$25.1K 0.18% 134
2020
Q4
$823K Buy
2,006
+310
+18% +$129K 0.18% 128
2020
Q3
$702K Buy
+1,696
New +$682K 0.18% 134
2020
Q2
– Sell
-156
Closed -$49K – 746
2020
Q1
$49K Buy
+156
New +$52.6K 0.02% 465

Other funds holding HUM

Eudaimonia Partners's HUM Position: Q2 2022 in Review

Eudaimonia Partners sold out of Humana (HUM) in Q2 2022, closing a stake of 3,431 shares — an estimated $1.49M sold.

Eudaimonia Partners first reported a position in HUM in Q1 2020 and held it in 7 quarters. The position peaked at $1.49M in Q1 2022. 959 funds tracked by Wall St. Rank hold HUM as of Q2 2022.

  • Eudaimonia Partners reported no remaining Humana position as of Q2 2022 after selling out during the quarter.
  • Eudaimonia Partners sold 3,431 Humana shares in Q2 2022, an estimated $1.49M.
  • Eudaimonia Partners first reported a position in Humana in Q1 2020 and held it in 7 quarters.
  • Eudaimonia Partners's Humana position peaked at $1.49M in Q1 2022.
  • 959 funds tracked by Wall St. Rank held Humana as of Q2 2022.

Based on Eudaimonia Partners's 13F filing for Q2 2022, filed 9 Aug 2022.